Issue 12/2022
Content (22 Articles)
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review
Delphine Hudry, Stéphanie Bécourt, Giovanni Scambia, Anna Fagotti
Targeting the PI3K Pathway in Gynecologic Malignancies
Monica Avila, Michaela Onstad Grinsfelder, Melissa Pham, Shannon N. Westin
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy
Julia Dexter, Erin Lips, Paul DiSilvestro
Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse
Christina R. Washington, Kathleen N. Moore
New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology
Lodovico Balducci, Claire Falandry, Alan List
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?
Joanna M. Rhodes, Jacqueline C. Barrientos, Kanti R. Rai
Art Therapy in Advanced Cancer. A Mapping Review of the Evidence
Nadia Collette, Ivan Sola, Xavier Bonfill, Antonio Pascual
Role of Interventional Radiology in Pediatric Cancer Patients
Allison Aguado
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?
Yifan Wang, Mario Strazzabosco, David C. Madoff
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology
Yali Deng, Doan T. M. Ngo, Jessica K. Holien, Jarmon G. Lees, Shiang Y. Lim
Cardio-Oncology in Childhood: State of the Art
Elena Bennati, Francesca Girolami, Gaia Spaziani, Giovanni Battista Calabri, Claudio Favre, Iris Parrini, Fabiana Lucà, Angela Tamburini, Silvia Favilli
Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2 + Breast Cancer
Sneha Phadke
Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications
Prarthna V. Bhardwaj, Yara G. Abdou
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer
Mónica Cejuela, Andrea Vethencourt, Sonia Pernas
Immunotherapy in Biliary Tract Cancers: Where Are We?
Aparna Kalyan, Harshit Khosla, Richard D. Kim
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class
Jennifer A. Marks, Molly Wilgucki, Stephen V. Liu, Joshua E. Reuss
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?
Howard (Jack) West, Afsaneh Barzi, Debra Wong
Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer
Giuseppe Luigi Banna, Alex Friedlaender, Marco Tagliamento, Veronica Mollica, Alessio Cortellini, Sara Elena Rebuzzi, Arsela Prelaj, Abdul Rafeh Naqash, Edouard Auclin, Lucia Garetto, Laura Mezquita, Alfredo Addeo
Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider’s Perspective
Ginna Granroth, Allison Rosenthal, Maggie McCallen, Christopher Coughlin, Hollie Benson, Jeanne Palmer, Januario E. Castro, Javier Munoz
Targeted Therapy for Melanomas Without BRAF V600 Mutation
Jacob S. Choi, Sunandana Chandra
Correction to: Art Therapy in Advanced Cancer. A Mapping Review of the Evidence
Nadia Collette, Ivan Sola, Xavier Bonfill, Antonio Pascual
Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology
Lodovico Balducci, Claire Falandry, Alan List